Clinical Trials Directory

Trials / Completed

CompletedNCT00405522

Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children

Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children: Evaluation of Two Dose Combinations

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
34 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
3 Years – 12 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to compare intraoperative and recovery parameters in patients who receive two different dose combinations of propofol and remifentanil in patients undergoing a lumbar puncture.

Detailed description

Lumbar punctures (LP) are performed in approximately one thousand oncology patients per year at the Hospital for Sick Children. In a previous study, we determined the optimal dose of remifentanil which provides effective anesthesia with little or no movement during LP in children. The present study will determine the optimal dose combination of propofol and remifentanil to keep patients comfortable and still during the procedure while decreasing the incidence of side effects and allows for shorter recovery times and earlier discharge from the recovery room.

Conditions

Interventions

TypeNameDescription
DRUGPropofol 2.0 mg/kg + Remifentanil 1.5 ug/kgPatients in this arm of the study will receive 2.0 mg/kg propofol + 1.5 ug/kg remifentanil. An anesthesiologist will inject propofol mixed with lidocaine, followed immediately by remifentanil, diluted with 0.9% saline to a volume of 3 ml and administered as a bolus.
DRUGPropofol 4.0 mg/kg + Remifentanil 0.5 ug/kgPatients in this arm of the study will receive 4.0 mg/kg propofol + 0.5 ug/kg remifentanil. An anesthesiologist will inject propofol mixed with lidocaine, followed immediately by remifentanil, diluted with 0.9% saline to a volume of 3 ml and administered as a bolus.

Timeline

Start date
2006-11-01
Primary completion
2007-06-01
Completion
2007-06-01
First posted
2006-11-30
Last updated
2019-03-08
Results posted
2019-03-08

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00405522. Inclusion in this directory is not an endorsement.